FAIRVIEW NORTHLAND REG
1. Target Overview & Investment Thesis
FAIRVIEW NORTHLAND REG is a 34-bed suburban community hospital in SHERBURNE, MN with $83.5M in net patient revenue and a 1.2% operating margin. The hospital serves a payer mix of 27.1% Medicare, 7.1% Medicaid, and 65.7% commercial.
Thesis: Turnaround. Our ML models identify $6.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.2% to 8.5% (+736bps).
| Net Revenue HCRIS | $83.5M |
| Current EBITDA COMPUTED | $971K |
| Operating Margin COMPUTED | 1.2% |
| Occupancy HCRIS | 46.5% |
| Revenue / Bed COMPUTED | $2.5M |
| Net-to-Gross HCRIS | 30.4% |
| Distress Probability ML | 47.6% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of 1.2% places it above the state median. Among 69 size-comparable peers (17-68 beds), the median margin is -3.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (17-68), prioritizing same-state peers. 69 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| FAIRVIEW NORTHLAND REG (Target) | MN | 34 | $83.5M | 1.2% |
| LAKEVIEW MEMORIAL | MN | 68 | $411.9M | 60.9% |
| GILLETTE CHILDRENS SPECIALTY H | MN | 60 | $266.7M | -6.3% |
| OLMSTED MEDICAL CENTER | MN | 61 | $217.6M | -13.6% |
| CUYUNA REGIONAL MEDICAL CENTER | MN | 25 | $180.8M | -4.0% |
| ST. MARYS REGIONAL HEALTH CENT | MN | 36 | $167.8M | 3.1% |
| MAYO CLINIC HEALTH SYSTEM - RE | MN | 27 | $149.3M | 1.8% |
| ESSENTIA HEALTH VIRGINIA | MN | 49 | $132.0M | -5.0% |
| NEW ULM MEDICAL CENTER | MN | 24 | $128.6M | 4.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $53K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $971K |
| + RCM Uplift | +$6.1M |
| Pro Forma EBITDA | $7.1M |
| Current Margin | 1.2% |
| Pro Forma Margin | 8.5% |
| WC Released (1x) | $3.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.5M | $67.9M | 45.42x | 114.5% |
| Base (11x exit) | 10.0x | 11.0x | $1.5M | $75.1M | 50.29x | 118.9% |
| Bull Case | 9.0x | 11.0x | $1.3M | $95.9M | 71.32x | 134.8% |
| Bull (12x exit) | 9.0x | 12.0x | $1.3M | $105.0M | 78.10x | 139.1% |
| Bear Case | 11.0x | 10.0x | $1.6M | $36.6M | 22.30x | 86.1% |
| Bear (11x exit) | 11.0x | 11.0x | $1.6M | $40.8M | 24.85x | 90.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 69 hospitals with 17-68 beds
- Same-state prioritization (n=70)
- Comp margins: P25=-8.5% / P50=-3.3% / P75=2.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.